These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 6398430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
    Piazza V, Villa G, Galli F, Segagni S, Bovio G, Poggio F, Picardi L, Bianco L, Salvadeo A, Barosi G.
    Nephrol Dial Transplant; 1992; 7(5):438-42. PubMed ID: 1321381
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda.
    Cainelli T, Di Padova C, Marchesi L, Gori G, Rovagnati P, Podenzani SA, Bessone E, Cantoni L.
    Br J Dermatol; 1983 May; 108(5):593-600. PubMed ID: 6849826
    [Abstract] [Full Text] [Related]

  • 8. Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion.
    Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Pantaleoni M, Jensen J, Ventura E.
    Br J Dermatol; 1986 May; 114(5):621-9. PubMed ID: 3718853
    [Abstract] [Full Text] [Related]

  • 9. [Experiences with iron elimination therapy in porphyria cutanea tarda].
    Haneke E, Schwartze G.
    Z Gesamte Inn Med; 1971 Nov 15; 26(22):710-6. PubMed ID: 5141034
    [No Abstract] [Full Text] [Related]

  • 10. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O.
    Acta Derm Venereol Suppl (Stockh); 1982 Nov 15; 100():107-18. PubMed ID: 6962627
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic and pathogenetic aspects of porphyria cutanea tarda].
    Köstler E, Seebacher C, Riedel H, Kemmer C.
    Hautarzt; 1986 Apr 15; 37(4):210-6. PubMed ID: 3009356
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD, Jones KG.
    Can Med Assoc J; 1979 Apr 07; 120(7):803-7. PubMed ID: 427687
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Ventura E.
    J Lab Clin Med; 1986 Jan 07; 107(1):36-42. PubMed ID: 3941293
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.